Ionis Pharmaceuticals Inc. (IONS) Fundamentals

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy. Ionis subsequently brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019).
SHARE INFORMATION
Market Cap$ 5,325,927,396
Shares Outstanding141,797,854
Float119,746,820
Percent Float84.45%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 810,456,000
Latest Fiscal EPS$ -0.19
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions823
Institutional Holdings Date2022-05-31
Institutional Bought Previous 3 Months11,280,267
Institutional Holdings Percent178.2%
Institutional Sold Previous 3 Months20,230,419
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months3,328
Insider Holdings Percent0.6
Insider Sold Previous 3 Months-
Insider Shares Owned908,825
TRADING INFO
52 Week High$ 44.42
52 Week Low$ 25.04
52 Week High Change$ -5.03
21 Day Moving Average$ 36.0305
21 Day Extended Moving Average$ 36.8331
50 Day Moving Average$ 37.2986
50 Day Extended Moving Average$ 36.6873
200 Day Moving Average$ 34.0567
200 Day Extended Moving Average$ 36.3045
10 Day Average Volume962,074
20 Day Average Volume931,503
30 Day Average Volume1,037,651
50 Day Average Volume1,089,212
Alpha-0.007081
Beta0.7742
Standard Deviation0.096186
R20.145299
7 Day Price Change$ 0.32
7 Day Percent Change0.86%
21 Day Price Change$ 2.56
21 Day Percent Change7.31%
30 Day Price Change$ -0.07
30 Day Percent Change-0.19%
Month to Date Price Change$ 1.04
Month to Date Percent Change2.85%
Quarter to Date Price Change$ 0.52
Quarter to Date Percent Change1.4%
180 Day Price Change$ 6.93
180 Day Percent Change22.62%
200 Day Price Change$ 8.09
200 Day Percent Change27.45%
Year to Date Price Change$ 7.13
Year to Date Percent Change23.43%

Ionis Pharmaceuticals Inc. (IONS) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin2.3%
Pre-Tax Profit Margin8.1%
Profit Margin Count-0.63%
Gross Margin98.5%
Profit Margin TOT-0.63%
INCOME STATEMENTS
Revenue$ 840,768,000
Revenue Per Share$ 5.9293
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book7.90
Total Debt To Equity1.70
Int Coverage0.00
Current Ratio9.90
Leverage Ratio3.90
Quick Ratio9.10
Long Term Debt To Capital0.63
VALUATION MEASURES
PE Ratio-3,797.00
Enterprise Value$ 4,553,891,516
Price to Sales6.3346
Price to Free Cash152.20
PE High Last 5 Years1,196.20
Price To Book7.60
Price To Cash Flow99.70
PE Low Last 5 Years-51.80
Price to Tangible Book7.90
MANAGEMENT EFFECTIVENESS
Receivables Turnover17.30
Invoice Turnover0.60
Assets Turnover0.40
Return Assets-0.17
Return on Equity-0.58
Return on Capital-0.10

Ionis Pharmaceuticals Inc. (IONS) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOBrett P. Monia
Emplyoees660
Last AuditUE
CIK0000874015
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address2855 Gazelle Court
Carlsbad, CA 92010
Websitehttps://www.ionispharma.com
Facsimile+1 760 268-4922
Telephone+1 760 931-9200
EmailWWalke@ionisph.com
Your Recent History
NASDAQ
IONS
Ionis Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220701 01:43:03